
Billy D. Chism
Examiner (ID: 5558)
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1654, 1653 |
| Total Applications | 335 |
| Issued Applications | 112 |
| Pending Applications | 142 |
| Abandoned Applications | 81 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7224346
[patent_doc_number] => 20040072729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'High oxygen affinity PEG-hemoglobin as treatment for brain stroke'
[patent_app_type] => new
[patent_app_number] => 10/267833
[patent_app_country] => US
[patent_app_date] => 2002-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 8653
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20040072729.pdf
[firstpage_image] =>[orig_patent_app_number] => 10267833
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/267833 | High oxygen affinity PEG-hemoglobin as treatment for brain stroke | Oct 9, 2002 | Abandoned |
Array
(
[id] => 1037555
[patent_doc_number] => 06872704
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-03-29
[patent_title] => 'Acidic mammalian proteins and polynucleotides encoding the same'
[patent_app_type] => utility
[patent_app_number] => 10/268919
[patent_app_country] => US
[patent_app_date] => 2002-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 44326
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/872/06872704.pdf
[firstpage_image] =>[orig_patent_app_number] => 10268919
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/268919 | Acidic mammalian proteins and polynucleotides encoding the same | Oct 8, 2002 | Issued |
Array
(
[id] => 956276
[patent_doc_number] => 06956027
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-10-18
[patent_title] => 'N-terminally chemically modified protein compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 10/264846
[patent_app_country] => US
[patent_app_date] => 2002-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 11656
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/956/06956027.pdf
[firstpage_image] =>[orig_patent_app_number] => 10264846
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/264846 | N-terminally chemically modified protein compositions and methods | Oct 3, 2002 | Issued |
Array
(
[id] => 6674812
[patent_doc_number] => 20030060415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-27
[patent_title] => 'Treatment of a coronary condition by delivery of therapeutics to the pericardial space'
[patent_app_type] => new
[patent_app_number] => 10/263408
[patent_app_country] => US
[patent_app_date] => 2002-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24248
[patent_no_of_claims] => 86
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20030060415.pdf
[firstpage_image] =>[orig_patent_app_number] => 10263408
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/263408 | Treatment of a coronary condition by delivery of therapeutics to the pericardial space | Oct 1, 2002 | Abandoned |
Array
(
[id] => 6852107
[patent_doc_number] => 20030144310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'Molecules specific for NPFF receptors and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/253288
[patent_app_country] => US
[patent_app_date] => 2002-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13812
[patent_no_of_claims] => 89
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20030144310.pdf
[firstpage_image] =>[orig_patent_app_number] => 10253288
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/253288 | Molecules specific for NPFF receptors and uses thereof | Sep 23, 2002 | Abandoned |
Array
(
[id] => 7281263
[patent_doc_number] => 20040063640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => 'PEPTIDOMIMETIC GLUTATHIONE ANALOGS'
[patent_app_type] => new
[patent_app_number] => 10/246424
[patent_app_country] => US
[patent_app_date] => 2002-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9071
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20040063640.pdf
[firstpage_image] =>[orig_patent_app_number] => 10246424
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/246424 | Peptidomimetic glutathione analogs | Sep 18, 2002 | Issued |
Array
(
[id] => 7270358
[patent_doc_number] => 20040058876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-25
[patent_title] => 'Secondary binding site of dipeptidyl peptidase IV (DP IV)'
[patent_app_type] => new
[patent_app_number] => 10/246817
[patent_app_country] => US
[patent_app_date] => 2002-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 20080
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20040058876.pdf
[firstpage_image] =>[orig_patent_app_number] => 10246817
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/246817 | Secondary binding site of dipeptidyl peptidase IV (DP IV) | Sep 17, 2002 | Abandoned |
Array
(
[id] => 6697247
[patent_doc_number] => 20030109441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'Use of lactogenic and somatogenic hormones to enhance reproductive efficiency in mammals'
[patent_app_type] => new
[patent_app_number] => 10/246327
[patent_app_country] => US
[patent_app_date] => 2002-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10106
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0109/20030109441.pdf
[firstpage_image] =>[orig_patent_app_number] => 10246327
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/246327 | Use of lactogenic and somatogenic hormones to enhance reproductive efficiency in mammals | Sep 17, 2002 | Abandoned |
Array
(
[id] => 6808727
[patent_doc_number] => 20030198666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-23
[patent_title] => 'Oral insulin therapy'
[patent_app_type] => new
[patent_app_number] => 10/237138
[patent_app_country] => US
[patent_app_date] => 2002-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 53067
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20030198666.pdf
[firstpage_image] =>[orig_patent_app_number] => 10237138
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/237138 | Oral insulin therapy | Sep 5, 2002 | Abandoned |
Array
(
[id] => 439464
[patent_doc_number] => 07259143
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-21
[patent_title] => 'Method of extending the dose range of vitamin D compounds'
[patent_app_type] => utility
[patent_app_number] => 10/235244
[patent_app_country] => US
[patent_app_date] => 2002-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5960
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/259/07259143.pdf
[firstpage_image] =>[orig_patent_app_number] => 10235244
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/235244 | Method of extending the dose range of vitamin D compounds | Sep 4, 2002 | Issued |
Array
(
[id] => 6814081
[patent_doc_number] => 20030073631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Modified bdnf'
[patent_app_type] => new
[patent_app_number] => 10/220315
[patent_app_country] => US
[patent_app_date] => 2002-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8052
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20030073631.pdf
[firstpage_image] =>[orig_patent_app_number] => 10220315
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/220315 | Modified BDNF | Aug 28, 2002 | Issued |
Array
(
[id] => 758458
[patent_doc_number] => 07015305
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-03-21
[patent_title] => 'Process for preparing glycopeptide derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/226988
[patent_app_country] => US
[patent_app_date] => 2002-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4567
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 289
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/015/07015305.pdf
[firstpage_image] =>[orig_patent_app_number] => 10226988
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/226988 | Process for preparing glycopeptide derivatives | Aug 22, 2002 | Issued |
| 10/089971 | METHOD OF TREATING METABOLIC DISORDERS | Aug 12, 2002 | Abandoned |
Array
(
[id] => 6693048
[patent_doc_number] => 20030040480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-27
[patent_title] => 'Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptides'
[patent_app_type] => new
[patent_app_number] => 10/200473
[patent_app_country] => US
[patent_app_date] => 2002-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 20496
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20030040480.pdf
[firstpage_image] =>[orig_patent_app_number] => 10200473
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/200473 | Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptides | Jul 18, 2002 | Abandoned |
Array
(
[id] => 539396
[patent_doc_number] => 07166296
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-23
[patent_title] => 'Pharmaceutical formulations and ligands for use therein; mimetics for UEA-1'
[patent_app_type] => utility
[patent_app_number] => 10/187550
[patent_app_country] => US
[patent_app_date] => 2002-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 14466
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/166/07166296.pdf
[firstpage_image] =>[orig_patent_app_number] => 10187550
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/187550 | Pharmaceutical formulations and ligands for use therein; mimetics for UEA-1 | Jul 1, 2002 | Issued |
Array
(
[id] => 6813247
[patent_doc_number] => 20030072797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Pharmaceutical compositions for oral administration'
[patent_app_type] => new
[patent_app_number] => 10/149428
[patent_app_country] => US
[patent_app_date] => 2002-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5997
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20030072797.pdf
[firstpage_image] =>[orig_patent_app_number] => 10149428
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/149428 | Pharmaceutical compositions for oral administration | Jun 23, 2002 | Issued |
| 10/048444 | Use of quinic, shikimic acids and their derivatives for preparing mannose receptor ligands | Jun 18, 2002 | Abandoned |
| 09/959263 | Inhibition of proteasome function induces programmed cell death in endothelial cells | Jun 11, 2002 | Abandoned |
Array
(
[id] => 6756538
[patent_doc_number] => 20030004315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-02
[patent_title] => 'Collagen'
[patent_app_type] => new
[patent_app_number] => 10/129129
[patent_app_country] => US
[patent_app_date] => 2002-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8597
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20030004315.pdf
[firstpage_image] =>[orig_patent_app_number] => 10129129
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/129129 | Collagen | May 28, 2002 | Abandoned |
Array
(
[id] => 6749898
[patent_doc_number] => 20030044418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Method and compositions for inhibiting thrombin-induced coagulation'
[patent_app_type] => new
[patent_app_number] => 10/142935
[patent_app_country] => US
[patent_app_date] => 2002-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12148
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20030044418.pdf
[firstpage_image] =>[orig_patent_app_number] => 10142935
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/142935 | Method and compositions for inhibiting thrombin-induced coagulation | May 12, 2002 | Issued |